Literature DB >> 27230239

Do adults aged 70 years or older with acute myeloid leukemia benefit from allogeneic hematopoietic cell transplantation?

A Rashidi1, J F DiPersio1, P Westervelt1, R Vij1, C N Abboud1, R Romee1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27230239     DOI： 10.1038/leu.2016.99

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  Survival for older patients with acute myeloid leukemia: a population-based study.

Authors:  Betul Oran; Daniel J Weisdorf
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012.

Authors:  A G Dinmohamed; O Visser; Y van Norden; N M A Blijlevens; J J Cornelissen; G A Huls; P C Huijgens; P Sonneveld; A A van de Loosdrecht; G J Ossenkoppele; B Löwenberg; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-07-17       Impact factor: 11.528

3.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

4.  IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade.

Authors:  P A Rowlings; D Przepiorka; J P Klein; R P Gale; J R Passweg; P J Henslee-Downey; J Y Cahn; S Calderwood; A Gratwohl; G Socié; M M Abecasis; K A Sobocinski; M J Zhang; M M Horowitz
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

5.  Umbilical Cord Blood Transplantation Outcomes in Acute Myelogenous Leukemia/Myelodysplastic Syndrome Patients Aged ≥70 Years.

Authors:  Karamjeet S Sandhu; Claudio Brunstein; Todd DeFor; Nelli Bejanyan; Mukta Arora; Erica Warlick; Daniel Weisdorf; Celalettin Ustun
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-28       Impact factor: 5.742

6.  Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

Authors:  Steven M Devine; Kouros Owzar; William Blum; Flora Mulkey; Richard M Stone; Jack W Hsu; Richard E Champlin; Yi-Bin Chen; Ravi Vij; James Slack; Robert J Soiffer; Richard A Larson; Thomas C Shea; Vera Hars; Alexander B Sibley; Sergio Giralt; Shelly Carter; Mary M Horowitz; Charles Linker; Edwin P Alyea
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

7.  Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades.

Authors:  Mya S Thein; William B Ershler; Ahmedin Jemal; Jerome W Yates; Maria R Baer
Journal:  Cancer       Date:  2013-04-30       Impact factor: 6.860

Review 8.  To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century.

Authors:  C Ustun; H M Lazarus; D Weisdorf
Journal:  Bone Marrow Transplant       Date:  2013-05-06       Impact factor: 5.483

9.  Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Authors:  Gunnar Juliusson; Petar Antunovic; Asa Derolf; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Ulf Tidefelt; Anders Wahlin; Martin Höglund
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113

10.  Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States.

Authors:  Bruno C Medeiros; Sacha Satram-Hoang; Deborah Hurst; Khang Q Hoang; Faiyaz Momin; Carolina Reyes
Journal:  Ann Hematol       Date:  2015-03-20       Impact factor: 3.673
  10 in total
  3 in total

1.  Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan.

Authors:  Masamichi Isobe; Takaaki Konuma; Masayoshi Masuko; Naoyuki Uchida; Shigesaburo Miyakoshi; Yasuhiro Sugio; Shuro Yoshida; Masatsugu Tanaka; Yoshiko Matsuhashi; Norimichi Hattori; Makoto Onizuka; Nobuyuki Aotsuka; Yasushi Kouzai; Atsushi Wake; Takafumi Kimura; Tatsuo Ichinohe; Yoshiko Atsuta; Masamitsu Yanada
Journal:  Ann Hematol       Date:  2021-02-23       Impact factor: 3.673

Review 2.  Bridging Strategies to Allogeneic Transplant for Older AML Patients.

Authors:  Judith Hecker; Isabella Miller; Katharina S Götze; Mareike Verbeek
Journal:  Cancers (Basel)       Date:  2018-07-11       Impact factor: 6.639

3.  Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation.

Authors:  H Joachim Deeg
Journal:  Blood Adv       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.